PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2013
CASE
AUTH/2665/11/13 Genzyme

AUTH/2665/11/13: Genzyme (Sanofi) – clinical trial disclosure delays for Mozobil; no breach for Renvela (timing pre-Code)

Public complaint about clinical trial transparency data. Panel found delayed disclosure for one UK-involved Mozobil trial (breach Clauses 9.1, 21.3). Renvela issues…

2008
CASE
AUTH/2084/1/08 Novartis Pharmaceuticals UK

AUTH/2084/1/08: Anonymous v Novartis β€” hospitality at educational meeting (no breach)

Anonymous complaint alleged excessive hospitality and poor rep conduct at a Novartis-sponsored restaurant meeting. Panel said costs/drinks were at the outer limits…

2015
CASE
AUTH/2815/12/15 Piramal Healthcare UK

AUTH/2815/12/15: AbbVie v Piramal β€” Sevoflurane β€œdrop test” leaflet treated as promotional; missing cost, AE statement and date

A sevoflurane packaging β€œdrop test” leaflet was ruled promotional. It omitted the medicine’s cost, the mandatory adverse event reporting statement and the…

2016
CASE
AUTH/2853/6/16 GlaxoSmithKline

AUTH/2853/6/16: Anonymous v GlaxoSmithKline (Telegraph Online malaria vaccine corporate ad) – No breach

Anonymous complaint alleged GSK promoted an unlicensed malaria vaccine to the public via a Telegraph Online ad. PMCPA ruled the 30-second video…

2016
CASE
AUTH/2919/12/16 Merck Sharp & Dohme ⭐ Case of the Week

AUTH/2919/12/16: Anonymous (non-contactable) v Merck Sharp & Dohme β€” no breach (representative conduct allegation)

Anonymous GP alleged an MSD representative brought her daughter to meetings. MSD found no record of any complaint. Panel said allegation not…

2016
CASE
AUTH/2865/8/16 Sanofi

AUTH/2865/8/16: Anonymous (non-contactable) v Sanofi β€” MEGS nurse advisor service (No breach)

Anonymous complaint alleged industry-funded audits/workshops and coercive behaviour via a nurse-led consultancy. Panel found no evidence against Sanofi; its MEGS nurse advisor…

2016
CASE
AUTH/2920/12/16 UCB Pharma

UCB: internal β€œtake-home naloxone” poster deemed briefing material and breached high standards (AUTH/2920/12/16)

Anonymous ex-rep alleged off-licence promotion of Naloxone Minijet. Panel found no off-licence breach, but ruled an internal conference poster functioned as rep…

2017
CASE
AUTH/2941/2/17 Merck Sharp & Dohme

AUTH/2941/2/17: Health professional consultant v Merck Sharp & Dohme (webcast invitation) – No breach

MSD sent a third-party email invite (via Pulse) to a cardiovascular webcast labelled promotional but with no product named and no prescribing…

2017
CASE
AUTH/2953/4/17 Dr Falk Pharma

AUTH/2953/4/17: Dr Falk journal ad for Salofalk Granules – β€œstep change” headline ruled misleading

A competitor challenged a Salofalk Granules journal ad. The PMCPA ruled the β€œstep change… Now that’s progress” headline misleading, exaggerated and unsubstantiated…

2017
CASE
AUTH/2951/4/17 Sanofi ⭐ Case of the Week

Sanofi breached ABPI Code over Toujeo β€œLatest Data” app implying hypoglycaemia benefit from clamp-study PK/PD data (AUTH/2951/4/17)

Toujeo iPad β€œLatest Data” app design and training encouraged linking clamp-study PK/PD variability data to reduced hypoglycaemia. Panel found the material misleading…

2018
CASE
AUTH/3036/4/18 Concordia International Rx

AUTH/3036/4/18: Health professional v Concordia (Morphgesic SR journal ad) – No breach

A health professional alleged a Morphgesic SR ad used outdated prescribing information (May 2013). The Panel found the PI had a Dec…

2007
CASE
AUTH/1980/3/07 Sanofi

Sanofi Pasteur MSD: Gardasil scrutiny after Guardian articlesβ€”journalist payments and sponsorship disclosure (AUTH/1980/3/07, AUTH/1983/3/07)

Guardian articles criticised Gardasil promotion and a Paris cervical cancer summit. Panel found breaches for inadequate upfront sponsorship disclosure on invitations and…

2007
CASE
AUTH/2056/10/07 Novo Nordisk

Eli Lilly v Novo Nordisk: Levemir ad implied weight loss via β€œChanging Figures” strapline and imagery (AUTH/2056/10/07)

A Levemir journal ad showing overweight women in a pool with the strapline β€œLevemir is changing figures” was ruled misleading/ambiguous, implying weight…

2006
CASE
AUTH/1895/10/06 AstraZeneca

AstraZeneca: overnight stay for short regional meeting ruled inappropriate (AUTH/1895/10/06)

Anonymous complaint about AstraZeneca-sponsored psychiatrist meetings. Panel upheld one breach: overnight accommodation for a 4.5-hour Coventry meeting was not justified (Clause 19.1).…

2007
CASE
AUTH/1962/2/07 AstraZeneca ⭐ Case of the Week

AUTH/1962/2/07: PCT adviser v AstraZeneca – Symbicort budget impact model presented to practice managers (no breach)

A PCT adviser challenged AstraZeneca’s Symbicort budget impact presentation to GP practice managers and meeting sponsorship. Panel found the audience and hospitality…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training